Selank, 5mg

Product Category

Neuropsychiatric Peptides, Anxiolytics & Nootropic Modulators

Action on the Human Body

Selank is a synthetic heptapeptide derived from the naturally occurring immunomodulatory peptide Tuftsin, featuring a stabilized Pro-Gly-Pro addition at its C-terminus to block enzymatic degradation. It functions as a selective anxiolytic and nootropic modifier without displaying central nervous system sedative properties. Selank works by binding directly to GABAergic neural networks, altering serotonin and norepinephrine turnover indexes within prefrontal cortical regions, and directly augmenting Brain-Derived Neurotrophic Factor (BDNF) expression in the hippocampus. Furthermore, it regulates the breakdown of endogenous enkephalins to sustain native pain management thresholds and optimizes white blood cell cytokine expression to provide robust neuroimmune stabilization.

What to Expect if Consumed

Users report an immediate, profound clearing of internal anxious loop patterns, enhanced cognitive processing speed during high-stress activities, improved verbal articulation, and a calm mental focus completely free from the fatigue or addiction risks associated with traditional options.

Possible Therapy Combinations

Pairs exceptionally well with Semax (5mg) to form an elite, comprehensive nootropic performance and emotional resilience protocol, or stacked alongside DSIP to manage chronic sleep architecture defects.

Molecular Formula & Chemical Composition

Sequence: Thr-Lys-Pro-Arg-Pro-Gly-Pro. Molecular Formula: C33H57N11O9. Purity: >99% Pure HPLC Certified Powder Mass via strict analytical validation.

WARNING: This peptide compound must be handled and utilized exclusively under very high, correct professional and qualified medical supervision. Misuse can lead to unintended biological variations.

Scientific References

1. Kozlovskaya, M. M., et al. (2003). ‘Selank: A novel synthetic heptapeptide with anxiolytic and nootropic properties.’ Drugs of the Future.
2. Uchakina, O. N., et al. (2026). ‘Immunomodulatory and neuro-protective adjustments driven by the heptapeptide Selank under chronic emotional stress models.’ Journal of Neuroimmunology.